2023 Webinar: Embracing Change: A Shift in Steatotic Liver Disease Nomenclature from NAFLD to MASLD-Webinar Recording

Video Transcription

Video Summary

The webinar focused on the nomenclature change in steatotic liver disease (SLD) from Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). The speakers discussed the rationale for the nomenclature change and the implications for patient care and research. They highlighted the need for a multidisciplinary approach to SLD and emphasized the importance of addressing both the metabolic dysfunction and alcohol consumption in patient management. The speakers also stressed the need for further research on the overlap between MASLD and ALD (alcoholic liver disease) and the development of biomarkers to accurately diagnose and monitor SLD. They discussed the potential impact of the nomenclature change on clinical care, patient outcomes, and public health policies. Overall, the webinar provided insights into the evolving understanding of SLD and the challenges and opportunities in its diagnosis and management.

Keywords

nomenclature change

steatotic liver disease

Metabolic Dysfunction Associated Steatotic Liver Disease

patient care

research

multidisciplinary approach

alcohol consumption

biomarkers

clinical care